Loading insider details...
Beta
Latest Form 4 (Oct 13, 2026): Grant/Award of 200,000 CVKD shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 13, 2026 | Cadrenal Therapeutics, Inc. (CVKD) | Grant/Award | 200,000 | n/a |
| Jul 2, 2026 | Cadrenal Therapeutics, Inc. (CVKD) | Sale | 7,400 | $22.4K |
| Jun 27, 2026 | Cadrenal Therapeutics, Inc. (CVKD) | Sale | 2,127 | $6.4K |
| Jun 24, 2026 | Cadrenal Therapeutics, Inc. (CVKD) | Sale | 9,167 | $32.5K |
| Jun 18, 2026 | Cadrenal Therapeutics, Inc. (CVKD) | Sale | 3,613 | $11.5K |
| Jun 16, 2026 | Cadrenal Therapeutics, Inc. (CVKD) | Sale | 1,462 | $6.0K |
| Jun 11, 2026 | Cadrenal Therapeutics, Inc. (CVKD) | Sale | 5,893 | $25.8K |
| Jun 5, 2026 | Cadrenal Therapeutics, Inc. (CVKD) | Sale | 2,323 | $9.9K |
| Jun 3, 2026 | Cadrenal Therapeutics, Inc. (CVKD) | Sale | 303 | $1.5K |
| May 29, 2026 | Cadrenal Therapeutics, Inc. (CVKD) | Sale | 6,476 | $37.3K |